Can we know more about atherosclerosis in cyanotic patients with congenital heart disease—the potential role of sphingosine-1-phosphate?
The values of the analyzed biochemical and clinical factors (except for the reduced HDL fraction), the lack of inflammatory factor activity, and the increased S1P concentration indicate the dominance of antiatherosclerotic activity in this population. FMD and IMT are preserved, which suggests that the risk of early atherosclerotic changes in this group is comparable to the remaining population.
Authors
- Sonia Nartowicz (ORCID: https://orcid.org/0000-0003-1556-7379)
- Olga Trojnarska
- Artur Cieślewicz (ORCID: https://orcid.org/0000-0001-9918-5989)
- Magdalena Janus (ORCID: https://orcid.org/0000-0002-9500-6776)
- Katarzyna Malesza
- Agnieszka Bartczak‐Rutkowska (ORCID: https://orcid.org/0000-0002-6607-9191)
- Marcin Gabriel
- Maciej Lesiak
Institutions
- Poznan University of Medical Sciences (PL)
Publication Details
- Journal
- Frontiers in Cardiovascular Medicine
- Published
- 2025-04-28
- DOI
- https://doi.org/10.3389/fcvm.2025.1531136
- Primary Topic
- Cardiovascular Function and Risk Factors
- Type
- article
- Field-Weighted Citation Impact
- 0.00